(Q49121500)

18 February 2018

title

The effect of the tachykinin NK(2) receptor antagonist MEN11420 (nepadutant) on neurokinin A-induced bronchoconstriction in asthmatics (English)

1 reference

18 February 2018

0 references

0 references

Venessa Schelfhout

1

1 reference

18 February 2018

Veerle Van De Velde

2

1 reference

18 February 2018

Carlo Maggi

3

1 reference

18 February 2018

Romain Pauwels

4

1 reference

18 February 2018

Guy Joos

5

1 reference

18 February 2018

publication date

1 October 2009

1 reference

18 February 2018

Therapeutic advances in respiratory disease

published in

1 reference

18 February 2018

volume

3

1 reference

18 February 2018

issue

5

1 reference

18 February 2018

page(s)

219-226

1 reference

18 February 2018

NK1 receptor stimulation causes contraction and inositol phosphate increase in medium-size human isolated bronchi

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

Role of tachykinins in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

Pro-inflammatory effects of substance P: new perspectives for the treatment of airway diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

Multifaceted approach to determine the antagonist molecular mechanism and interaction of ibodutant ([1-(2-phenyl-1R-[[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl]-ethylcarbamoyl)-cyclopentyl]-amide) at the human tachykinin NK2 rec

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

Role of tyrosine kinase pathways in ETB receptor activation of NHE3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

Characterization of the antibronchoconstrictor activity of MEN 11420, a tachykinin NK2 receptor antagonist, in guinea-pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809349741

21 January 2018

Identifiers

DOI

10.1177/1753465809349741

1 reference

18 February 2018

1 reference

18 February 2018